RPRX
Royalty Pharma plcNASDAQStock$59.02+0.22 (+0.37%)Mkt Cap 25.4BP/E 33.16Div Yield 1.55%Beta 0.42Vol 661.1KAvg Vol 3.8M
52W$34.90
$59.02
ETFs That Hold RPRX (Royalty Pharma plc)
1M
+3.38%
3M
+19.14%
6M
+46.05%
YTD
+51.88%
1Y
+59.26%
3Y
+88.98%
5Y
+53.18%
ETFs That Hold RPRX
Royalty Pharma plc is held by 195 ETFs. The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| VLLU | Harbor AlphaEdge Large Cap Value ETF (VLLU) | 0.53% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.06% |
| RKSG | Ruk Strategic Growth ETF | 0.98% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.00% |
| STMB | iShares Trust - iShares Factors US Mid Blend Style ETF | 0.34% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.15% |
| NZUS | State Street SPDR MSCI USA Climate Paris Aligned ETF | 0.56% |
| QWLD | State Street SPDR MSCI World StrategicFactors ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.02% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.02% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.05% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.02% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.01% |
| GPAL | Goldman Sachs ActiveBeta Paris-Aligned U.S. Large Cap Equity ETF | 0.20% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.02% |
| LGCF | Themes US Cash Flow Champions ETF | 0.41% |
| STLC | iShares Trust - iShares Factors US Blend Style ETF | 1.03% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.01% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.02% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold RPRX?
Royalty Pharma plc (RPRX) is held by 195 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
What is the largest ETF that holds RPRX?
By fund size, VFLO (VictoryShares Free Cash Flow ETF) with $8.48B in AUM holds 1.79% of its portfolio in RPRX, representing $152.1M in market value.
What percentage of PBE is RPRX?
RPRX makes up 4.96% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is RPRX in the S&P 500?
RPRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.